Skip to main content
Eli Lilly and Company (ETR:LLY)
Germany flag Germany · Delayed Price · Currency is EUR
590.40
+12.60 (2.18%)
Aug 15, 2025, 5:35 PM CET

Eli Lilly and Company Revenue

Eli Lilly and Company had revenue of $15.56B USD in the quarter ending June 30, 2025, with 37.64% growth. This brings the company's revenue in the last twelve months to $53.26B, up 36.83% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.

Revenue (ttm)
$53.26B
Revenue Growth
+36.83%
P/S Ratio
11.85
Revenue / Employee
$1.13M
Employees
47,000
Market Cap
537.61B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.38B
Merck KGaA 21.22B
Bayer Aktiengesellschaft 46.17B
Fresenius SE & Co. KGaA 22.28B
Fresenius Medical Care AG 19.52B
Sartorius Aktiengesellschaft 3.47B
Fielmann Group AG 2.33B
Carl Zeiss Meditec AG 2.18B
Revenue Rankings

Eli Lilly and Company News

More News